| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Krainer Adrian R. is a Director at STOK. Recent filings cover 0 purchases and 4 sales. Those positions are worth an estimated $9.3M at current prices.
Our model assigns Krainer Adrian R. a below-average insider score of 37/100, based on 3 past trades. On a 3-month view, 33.3% of the rated trades came out ahead, averaging -5.9% over three months.
Krainer Adrian R.'s largest disclosed position is in STOK as Director, worth about $9.3M. The recent filings there lean toward selling, a net 114,187 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | STOK Stoke Therapeutics, Inc. | Director | Sell | 33,243 | $39.74 | $1,320,963.79 | -10.5% | -21.8% | - | |
| Nov 24, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 40,472 | $29.72 | $1,202,718.57 | -11.1% | +19.4% | - | |
| Nov 14, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 40,472 | $26.98 | $1,092,058.26 | -5.1% | +20.3% | - |